Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia

NCT02204371 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated as the asset was sold to another company who decided not to pursue this indication with this drug.

Conditions

Interventions

Sponsor

GlaxoSmithKline